EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Scope & Guideline

Empowering Researchers with Cutting-Edge Reviews

Introduction

Delve into the academic richness of EXPERT REVIEW OF MOLECULAR DIAGNOSTICS with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1473-7159
PublisherTAYLOR & FRANCIS AS
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 2001 to 2024
AbbreviationEXPERT REV MOL DIAGN / Expert Rev. Mol. Diagn.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressKARL JOHANS GATE 5, NO-0154 OSLO, NORWAY

Aims and Scopes

The 'Expert Review of Molecular Diagnostics' focuses on advancing the field of molecular diagnostics through comprehensive reviews and analyses of current methodologies, technologies, and applications. The journal emphasizes the integration of innovative diagnostic techniques within clinical settings, aiming to enhance patient outcomes and facilitate personalized medicine.
  1. Molecular Diagnostic Technologies:
    The journal covers a wide array of molecular diagnostic technologies, including next-generation sequencing, PCR, and liquid biopsy methods, emphasizing their applications in various diseases such as cancer, infectious diseases, and genetic disorders.
  2. Biomarker Discovery and Validation:
    A significant focus is placed on the identification and validation of biomarkers that can aid in the diagnosis, prognosis, and treatment response monitoring in various conditions, particularly cancers and chronic diseases.
  3. Point-of-Care Testing:
    The journal highlights the developments in point-of-care testing (POCT) technologies, examining their role in improving accessibility and timeliness of diagnostics, especially in resource-limited settings.
  4. Emerging Infectious Diseases and Diagnostics:
    Research on the molecular diagnostics of emerging infectious diseases is a core area, especially in the context of global health challenges such as the COVID-19 pandemic.
  5. Translational Medicine and Clinical Applications:
    The journal emphasizes the translation of laboratory research into clinical practice, focusing on how molecular diagnostic advancements can be integrated into routine healthcare to improve patient management.
Recent publications in the 'Expert Review of Molecular Diagnostics' have highlighted several emerging themes that reflect the evolving landscape of molecular diagnostics. These trends indicate a shift towards innovative technologies and methodologies that enhance diagnostic capabilities and patient outcomes.
  1. Liquid Biopsy and Non-invasive Diagnostics:
    There is a growing emphasis on the use of liquid biopsies for cancer detection and monitoring, as well as for other diseases, reflecting a trend towards non-invasive diagnostic methods that provide real-time insights into disease status.
  2. Integration of Artificial Intelligence in Diagnostics:
    The incorporation of artificial intelligence and machine learning techniques in diagnostic processes is trending, with studies focusing on improving diagnostic accuracy and efficiency through data-driven approaches.
  3. Multi-Omics Approaches:
    Research is increasingly adopting multi-omics strategies, combining genomics, proteomics, and metabolomics to provide a more comprehensive understanding of disease mechanisms and improve diagnostic precision.
  4. Point-of-Care Innovations:
    There is a notable increase in research related to innovative point-of-care testing solutions, especially in the context of rapid diagnostics for infectious diseases and chronic conditions, highlighting the need for accessible healthcare solutions.
  5. Biomarkers for Personalized Medicine:
    Emerging themes focus on the identification of biomarkers that can guide personalized treatment strategies, particularly in oncology, reflecting a trend towards tailored therapeutic approaches based on individual patient profiles.

Declining or Waning

Over the recent years, certain themes in the field of molecular diagnostics have seen a decline in prominence within the journal's publications. This section outlines these waning themes, reflecting shifts in research focus and emerging priorities.
  1. Traditional Diagnostic Methods:
    There has been a noticeable decrease in publications related to traditional diagnostic methods, such as histopathology and serological testing, as the field increasingly shifts towards molecular and genomic approaches.
  2. Basic Research without Clinical Application:
    Papers focusing solely on basic research without clear clinical implications or applications are becoming less frequent, as the journal prioritizes studies that bridge the gap between research and clinical practice.
  3. Single Biomarker Studies:
    Research centered around single biomarker assessments without a multi-omics or systems biology approach is declining, reflecting a trend towards more comprehensive diagnostic strategies that consider multiple biomarkers and pathways.
  4. Static Diagnostic Technologies:
    The exploration of static or outdated diagnostic technologies is waning, as the field moves towards innovative, dynamic, and high-throughput technologies that can provide better diagnostics.
  5. Non-integrative Studies:
    There is a decrease in studies that do not integrate molecular diagnostics with other clinical data or advanced analytics, as the trend is moving towards more holistic and integrative approaches to patient diagnostics.

Similar Journals

Diagnostics

Elevating Standards in Diagnostic Research
Publisher: MDPIISSN: Frequency: 12 issues/year

Diagnostics is a pioneering open-access journal published by MDPI, catering to the critical field of clinical biochemistry since its establishment in 2011. Based in Switzerland, this esteemed journal, with E-ISSN 2075-4418, has gained significant recognition within the academic community, reflected in its 2023 Scopus rankings placing it in Q2 for Clinical Biochemistry and showcasing its impact in related medical disciplines. With a commitment to disseminating high-quality research that advances the understanding of diagnostic techniques and methodologies, Diagnostics covers a broad spectrum of topics including biochemical markers, diagnostic imaging, and molecular diagnostics. The journal's open access model ensures that groundbreaking findings are readily available to researchers, professionals, and students alike, fostering an environment of knowledge sharing and collaboration. As the field of diagnostics continues to evolve, Diagnostics remains at the forefront, paving the way for innovations that enhance health outcomes globally.

Cold Spring Harbor Molecular Case Studies

Unveiling the complexities of molecular case studies.
Publisher: COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPTISSN: 2373-2873Frequency: 6 issues/year

Cold Spring Harbor Molecular Case Studies is a prestigious journal published by COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT, that has garnered considerable attention in the fields of Biochemistry, Genetics, and Molecular Medicine. With a focus on the intersection of molecular biology and clinical case studies, this journal serves as a key resource for researchers and practitioners seeking to explore novel insights into genetic disorders and biomedical advances. Its impact is underscored by its categorization in Q2 in various disciplines in 2023, reflecting its significance and influence within the academic community. Although currently not labeled as Open Access, Cold Spring Harbor Molecular Case Studies provides a rigorous platform for disseminating high-quality, peer-reviewed research that drives innovation and enhances understanding in these rapidly evolving fields. As a supporter of advancing scientific knowledge, this journal is essential for those dedicated to the exploration of molecular mechanisms and their clinical implications.

International Journal of Clinical and Experimental Pathology

Advancing Knowledge in Pathology and Beyond
Publisher: E-CENTURY PUBLISHING CORPISSN: 1936-2625Frequency: 12 issues/year

International Journal of Clinical and Experimental Pathology, published by E-CENTURY PUBLISHING CORP, serves as a vital resource for professionals in the field of pathology. With its ISSN 1936-2625, the journal has positioned itself within the competitive landscape of medical journals, achieving commendable rankings in Scopus, particularly in the categories of Pathology and Forensic Medicine (Rank #98/185) and Histology (Rank #38/58). Although its coverage in Scopus has been discontinued, the journal’s past contributions from 2009 to 2017 continue to be a touchstone for researchers interested in advancing their understanding of clinical and experimental pathology. The open-access format ensures accessibility to a wide audience, fostering collaboration and education in this essential medical discipline. By bridging clinical research and experimental findings, this journal plays a crucial role in disseminating knowledge and enhancing practices within pathology, making it an indispensable tool for researchers, professionals, and students alike.

Journal of Laboratory Physicians

Pioneering advancements in laboratory practices and innovations.
Publisher: THIEME MEDICAL PUBL INCISSN: 0974-2727Frequency: 4 issues/year

The Journal of Laboratory Physicians is a prestigious, peer-reviewed publication dedicated to advancing the field of laboratory medicine. Published by THIEME MEDICAL PUBL INC, this journal has established itself as a vital source of research and clinical insights since its inception, transitioning to Open Access in 2009 to broaden its reach and accessibility. With an ISSN of 0974-2727 and an E-ISSN of 0974-7826, it aims to provide a platform for professionals, researchers, and students engaged in laboratory-based studies to share critical findings and foster collaboration across disciplines. The journal's scope encompasses a wide range of topics relevant to laboratory physicians, ensuring that it remains an essential resource for those seeking to stay on the cutting edge of laboratory practices and innovations. By disseminating timely research and reviews, the Journal of Laboratory Physicians plays a crucial role in enhancing the quality of healthcare through improved laboratory services.

Expert Review of Proteomics

Bridging Theory and Practice in Proteomic Science.
Publisher: TAYLOR & FRANCIS LTDISSN: 1478-9450Frequency: 6 issues/year

Expert Review of Proteomics, published by TAYLOR & FRANCIS LTD, is a distinguished journal that focuses on the latest advancements in the field of proteomics, a critical area within biochemistry and molecular biology. With an ISSN of 1478-9450 and E-ISSN 1744-8387, this journal has been pivotal in disseminating high-quality research from its inception in 2004 to its planned convergence in 2024. Its influential position is reflected in its 2023 rankings, placing it in the Q2 category for both Biochemistry and Molecular Biology, alongside respectable Scopus rankings that rank it 118th and 141st in its respective categories. Despite its non-open access structure, Expert Review of Proteomics provides researchers and professionals with a vital platform for critical reviews and insights into proteomic methodologies, thus contributing significantly to the global scientific community. By bridging theoretical research with practical applications, it serves as an essential resource for those dedicated to advancing their knowledge and expertise in this dynamic field.

Asian Biomedicine

Bridging Knowledge Gaps in Biomedical Sciences
Publisher: WALTER DE GRUYTER GMBHISSN: 1905-7415Frequency: 6 issues/year

Asian Biomedicine, published by WALTER DE GRUYTER GMBH, serves as a crucial platform for disseminating pioneering research in the field of biomedical sciences. Established in 2008, this journal has carved its niche in the landscape of academic publishing, concentrating on a diverse array of topics within biochemistry, genetics, and molecular biology, as well as medicine. Though it currently holds a Q4 ranking in its category, it is dedicated to fostering academic discussions and advancing knowledge among researchers, professionals, and students alike. While the journal features a variety of access options, it is committed to ensuring that its content remains relevant and impactful, with an emphasis on the latest developments and research trends. The editorial board encourages submissions that address pressing biomedical issues, thus empowering contributors to engage meaningfully with the scientific community. With a broad international scope and a focus on quality, Asian Biomedicine is poised to play an increasingly important role in the advancement of biomedical research in Asia and beyond.

Annals of Laboratory Medicine

Exploring Breakthroughs in Clinical Biochemistry
Publisher: KOREAN SOC LABORATORY MEDICINEISSN: 2234-3806Frequency: 6 issues/year

Annals of Laboratory Medicine, published by the KOREAN SOC LABORATORY MEDICINE, stands as a pivotal resource for researchers and practitioners in the fields of clinical and medical biochemistry. With a strong Q2 ranking in both Biochemistry (medical) and Clinical Biochemistry, along with a prestigious Q1 status in miscellaneous Medicine categories, this journal emphasizes the significance of laboratory medicine in improving patient outcomes and advancing scientific understanding. Established in 2012, the journal has demonstrated an impressive trajectory of growth and scholarly contribution, making it a reliable source of high-quality research and insightful reviews. The journal utilizes open access, enhancing the reach of its findings across the global scientific community. Operating from South Korea, Annals of Laboratory Medicine aims to foster dialogue and collaboration among professionals, contributing to the continuous advancement of laboratory methodologies and diagnostics.

HLA

Advancing Immunology: Unleashing New Discoveries
Publisher: WILEYISSN: 2059-2302Frequency: 12 issues/year

HLA, published by WILEY, is a distinguished academic journal that serves as a vital resource in the fields of Immunology, Genetics, and Allergy. With an ISSN of 2059-2302 and an E-ISSN of 2059-2310, HLA aims to provide cutting-edge research and developments that expand our understanding of human immunology, particularly concerning histocompatibility and antigen systems. Although it currently holds a Q4 quartile ranking in several categories—including Genetics and Immunology—it offers a platform for innovative studies that can catalyze new insights within the scientific community. The journal operates on an Open Access model, ensuring broader accessibility and engagement with emerging discoveries. Researchers, healthcare professionals, and students alike are encouraged to contribute to and utilize this journal to foster advancements in this rapidly evolving field. For submissions and more information, authors can navigate directly to its online portal, embracing the ongoing discourse in immunological research.

ANNALES DE BIOLOGIE CLINIQUE

Advancing the Frontiers of Clinical Biology
Publisher: JOHN LIBBEY EUROTEXT LTDISSN: 0003-3898Frequency: 6 issues/year

ANNALES DE BIOLOGIE CLINIQUE is a prominent French journal dedicated to advancing the fields of Biochemistry, Genetics, Molecular Biology, Immunology, and Microbiology. Published by JOHN LIBBEY EUROTEXT LTD, this journal has been a pivotal resource since its inception in 1945, offering a rich archive of original research, reviews, and clinical studies that aim to bridge the gap between laboratory findings and clinical applications. Despite its ranking in the Q4 quartile within several scientific categories according to the 2023 Scopus rankings—positioning it at #395/636 in General Medicine and #198/221 in General Biochemistry—ANNALES DE BIOLOGIE CLINIQUE serves as a vital platform for emerging researchers and seasoned professionals alike, fostering collaboration and innovation in these vital areas of health science. As an essential tool for researchers and scholars, the journal does not currently provide open access; however, it continuously strives to enhance its impact and visibility in the scientific community through rigorous peer-reviewed content and educational contributions.

PATHOLOGY & ONCOLOGY RESEARCH

Transforming Understanding in Pathology and Oncology
Publisher: FRONTIERS MEDIA SAISSN: 1219-4956Frequency: 1 issue/year

PATHOLOGY & ONCOLOGY RESEARCH is a prominent international journal published by FRONTIERS MEDIA SA, dedicated to advancing the fields of pathology and oncology. Operating from the Netherlands, with a distinguished address in Switzerland, this journal plays a crucial role in disseminating significant research findings and insights from 1995 to 2024. With an ISSN of 1219-4956 and E-ISSN of 1532-2807, it is indexed in well-respected databases, facilitating access to a global audience of researchers and practitioners. Notably, the journal ranks in the Q3 category for Cancer Research (2023), while being recognized in the Q2 categories for both Medicine (Miscellaneous), Oncology, and Pathology and Forensic Medicine, reflecting its authoritative status in these vital disciplines. Scopus rankings further highlight its influence, with notable percentiles across various fields. Although it follows a subscription model, the journal remains committed to publishing high-quality, peer-reviewed research that bridges conceptual gaps and encourages further exploration in oncology and diagnostic pathology, making it an indispensable resource for academics and professionals engaged in these critical areas of medicine.